LIVN vs PRM
LIVN: LivaNova is a medical technology company specializing in innovative cardiovascular and neuromodulation therapies to improve patient lives. PRM: A diversified industrial manufacturer supplying specialized fire safety products, lubricant additives, electronic components, and medical device machinery to mission-critical markets with decentralized operations and value-driven pricing.
Side-by-side fundamentals
| Metric | LIVN | PRM | Edge |
|---|---|---|---|
| Price as of 2026-07-23 close | $78.61 | $34.06 | |
| Market cap as of 2026-07-24 | $4.3B | $5.5B | |
| P/E as of 2026-07-24 | 40.13 | n/a | |
| PEG as of 2026-07-24 | 3.92 | n/a | |
| Net margin as of 2026-07-24 | +7.5% | -26.9% | LIVN higher |
| Gross margin as of 2026-07-24 | +67.5% | +56.4% | LIVN higher |
| Operating margin as of 2026-07-24 | +13.1% | -29.2% | LIVN higher |
| ROE as of 2026-07-24 | +9.1% | -16.4% | LIVN higher |
| ROA as of 2026-07-24 | +4.2% | -7.0% | LIVN higher |
| Debt / equity as of 2026-07-24 | 0.24 | 1.11 | LIVN lower |
| Revenue growth (YoY) as of 2026-07-24 | +12.4% | +23.0% | PRM higher |
| Revenue CAGR (3y) SEC XBRL | +10.8% | +21.9% | PRM higher |
| Beta as of 2026-07-24 | 0.88 | 1.91 | |
| 1-year return as of 2026-07-23 close | +78.2% | +100.6% | PRM higher |
Fundamentals: Finnhub, as of 2026-07-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-23.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.